Texts and talks: a new push to get Mexican-American teens vaccinated against HPV

NCT ID NCT03209713

Ongoing Prevention Sponsor: Memorial Sloan Kettering Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a short educational session plus weekly text reminders can increase HPV vaccination rates among children of Mexican-American parents. About 672 parents will be randomly assigned to receive either education alone or education plus text reminders. The goal is to prevent HPV-related cancers by making sure kids complete the vaccine series.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: HPV vaccine education and text message reminders
What this could lead to: If successful, this approach could increase HPV vaccination rates in underserved communities, helping prevent HPV-related cancers.
What could go wrong: This is a behavioral study, not a drug trial, so results depend on participation and follow-through. It focuses on a specific group, so findings may not apply broadly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARENTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

human papilloma virus infection prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PARENTS

Contacts and locations

Locations

Alivio Medical Center

Chicago, Illinois, 60608, United States
Memorial Sloan Kettering Cancer Center

New York, New York, 10065, United States
Research, Education and Access to Community Health (REACH)

Las Vegas, Nevada, 89101, United States
The University of Texas at El Paso

El Paso, Texas, 79968, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.